celastrol has been researched along with Cirrhosis, Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Duanmu, J; Gu, J; Li, C; Liu, Z; Miao, J; Tao, J; Tu, M; Wang, Y; Xiong, B; Yao, W; Zhao, L | 1 |
1 other study(ies) available for celastrol and Cirrhosis, Liver
| Article | Year |
|---|---|
Celastrol exerts anti-inflammatory effect in liver fibrosis via activation of AMPK-SIRT3 signalling.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Gene Expression Regulation; Hepatic Stellate Cells; Inflammation; Liver Cirrhosis; Male; Pentacyclic Triterpenes; Rats; Rats, Sprague-Dawley; Sirtuins | 2020 |